Methylmercury (MeHg) causes neuronal death through different pathways. Particularly, we found that in cortical neurons it increased the expression of Repressor Element-1 Silencing Transcription Factor (REST), histone deacetylase (HDAC)4, Specificity Protein (Sp)1, Sp4, and reduced the levels of brain-derived neurotrophic factor (BDNF). Herein, in rat cortical neurons we investigated whether microRNA (miR)206 can modulate MeHg-induced cell death by regulating REST/HDAC4/ Sp1/Sp4/BDNF axis. MeHg (1 mM) reduced miR206 expression after both 12 and 24 h and miR206 transfection prevented MeHg-induced neuronal death. Furthermore, miR206 reverted MeHg-induced REST and Sp4 increase and BDNF reduction at gene and protein level, and reverted HDAC4 protein increase, but not HDAC4 mRNA upregulation. Moreover, since no miR206 seed sequences were identified in the 3'-untranslated regions (3'-UTRs) of REST and SP4, we investigated the role of JunD, that presents a consensus motif on REST, Sp4, and BDNF promoters. Indeed, MeHg increased JunD mRNA and protein levels, and JunD knockdown counteracted MeHg-induced REST, Sp4 increase, but not BDNF reduction. Furthermore, we identified a miR206 binding site in the 3'-UTR of JunD mRNA (miR206/JunD) and mutagenesis of miR206/JunD site reverted JunD luciferase activity reduction induced by miR206. Finally, miR206 prevented MeHg-increased JunD binding to REST and Sp4 promoters, and MeHg-reduced BDNF expression was determined by the increase of HDAC4 binding on BDNF promoter IV. Collectively, these results suggest that miR206 downregulation induced by MeHg exposure determines an upregulation of HDAC4, that in turn downregulated BDNF, and the activation of JunD that, by binding REST and Sp4 gene promoters, increased their expression.
the mechanisms by which it can induce neuronal death, glutamate (Glu) and calcium dyshomeostasis, as well as reactive oxygen species generation, are 3 important and interrelated phenomena that have been reported to mediate toxicity (Farina et al., 2011) . Specifically, by in vitro (Fujimura and Usuki, 2012; Pierozan et al., 2017) , in vivo (Juarez et al., 2002) , and ex vivo (Farina et al., 2003; Manfroi et al., 2004) experiments it has been demonstrated that in cortical cells MeHg induces neuronal death through the inhibition of astrocytic Glu uptake process that, resulting in higher Glu concentrations in the synaptic cleft, hyperstimulates N-methyl-D-aspartate receptors, which in turn increase the Na þ and Ca 2þ influx in neuronal cells (Farina et al., 2011) . Our previously paper demonstrated that MeHg can also induce neuronal cell death by increasing the expression of RE1-Silencing Transcription factor (REST) and by activating the histone deacetylase 4 (HDAC4)/Specificity protein 1 (Sp1)/Specificity protein 4 (Sp4)/brain-derived neurotrophic factor (BDNF) axis (Guida et al., 2017a) . Furthermore, it has been suggested that also microRNAs (miRNAs) could be involved in the toxic effects during MeHg exposure (Ding et al., 2016; Sanders et al., 2015; Wang et al., 2016; Williams et al., 2009) . However, which miRNA contributes to MeHg-induced neuronal death has not yet been characterized. In particular, miR206 that is expressed in many tissues, such as brain, skeletal muscle, adipose tissue, thyroid and liver (Nov ak et al., 2014) , has been suggested to play a role in the development of neurological diseases, such as ALS (Williams et al., 2009) , and alcohol dependence (Lewohl et al., 2011) . Since it has been demonstrated that miR206 downregulates HDAC4 and BDNF expression (Tapocik et al., 2014; Williams et al., 2009 ) and these proteins are involved in the neurotoxic effect of MeHg in cortical neurons (Guida et al., 2017a) , that have been already used to study MeHg-induced neurodetrimental effect (Fujimura and Usuki, 2012; Pierozan et al., 2017) , it appeared interest to investigate in these cells the possible role of miR206 to regulate MeHg-reduced neuronal survival by modulating the expression of REST/HDAC4/Sp1/Sp4/BDNF pathway.
MATERIALS AND METHODS
Materials and cell cultures. The compound MeHg (II) chloride (MeHg) (stock solution 100 mM) (cod: 442534) was purchased from Sigma (Milan, Italy) and dissolved in dimethyl sulfoxide (DMSO) from Sigma (Milan, Italy) at final nontoxic concentration of 0.1%. Culture media, sera, restriction enzymes, DNAmodifying enzymes, luciferase reporter kits, synthetic oligonucleotideshave been already published (Guida et al., 2017a) . Notably, all primers for polymerase chain reaction (PCR) experiments were designed using the Primer Express 3.0 software (Applied Biosystems, Foster City, USA). siRNA for JunD (siJunD) (SI01526840) and negative control (SI01685873) (siCTL) were purchased from Quiagen (Milan, Italy). Two sets of siRNAs (SI01526840 and SI01526826) were tested for JunD, and the set that was more effective was chosen for all the experiments (data not shown). miRNA-206-3p mimic (miR206) (ID: MC10409) and the non-targeting scramble miRNA (Scr), that was used as a negative control for miRNA-206 (NC No. cod: 4464058), were purchased from ThermoFisher (Milan, Italy). SH-SY5Y human neuroblastoma cells, rat embryonic cortical neurons (DIV 7-9), cell culture dishes and density of cells plated were prepared as previously reported (Guida et al., 2017a) . All the experiments in neurons were done according to the procedures described in experimental protocols approved by the Animal Ethical Committee of the "Federico II" University of Naples. Cell treatment with DMSO 0.1% is indicated as vehicle.
Drug treatment and transfections of cells with siRNAs or miR206. To study the effects of MeHg on miRNA-206 expression, neurons were treated with vehicle or MeHg at 1 mM for 6, 12, and 24 h. siRNAs and miRNAs transfections in cells were performed by using Lipofectamine LTX (15338-100, Invitrogen, Milan, Italy) at the concentration of 50 nM, as previously reported in Guida et al. (2017a) and Vinciguerra et al. (2014) . After 2 h of incubation with the transfection mix for neurons and 6 h for SH-SY5Y cells, the medium was replaced with a fresh one. After 24 h, neurons were lysed for the evaluation of miRNA206 expression by quantitative RT-PCR assay and for the expression of JunD by western blot analysis, whereas SH-SY5Y cells were harvested for luciferase assay experiments. For all the experiments containing siRNAs and miRNAs overexpression, at 24 h after transfections, cells were exposed to MeHg (1 mM) for 24 h and lysed for western blot, PCRreal-time and Chromatin Immunoprecipitation (ChIP) analysis. Transfection efficiency was approximately the same as previously reported in Guida et al. (2017b) .
Cloning of the 3 0 -untranslated region of rat JunD and luciferase assay experiments. A fragment of 878 bp (ENST00000252818.3), containing 3 0 -untranslated region (UTR) of rat JunD sequence was identified by Target scan software (7.1) (http://targetscan.org) (Agarwal et al., 2015) . By using 3 0 -UTR JunD primers from base 20485566 (5'-CAAATGCACAGAACAGCTGATTATACC-3', position Chr16: 20, 485, 566-20, 485, 584; ENSRNOG00000019568) -3' (Chr14: 33, 150, 054-33, 150, 074; ENSRNOG00000002074) and RV 5'-CCCGGATGTGATGTACGAA CT-3 (Chr14: 33, 149, 974-33, 149, 996; ENSRNOG00000002074) , for JunD FW 5'-TCAAGACCCTCAAAAGCCAGAA-3' (Chr16: 20, 485, 697-20, 485, 721; ENSRNOG00000019568) and RV 5'-TTGA CGTGGCTGAGGACTTTC-3 (Chr16: 20, 485, 620-20, 485, 642; ENSRNOG00000019568) , for REST exon B FW 5'-GATCGGA CGCCGGTAGC-3' (Chr14: 33, 150, 436-33, 150, 451; ENSRNOG00000002074) and RV 5'-CCATGCCCATGTTGC (Chr14: 33, 151, 946-33, 151, 963; ENSRNOG00000002074) , for total BDNF (BDNF tot) FW 5'-GGCCCAACGAAGAAAACCAT-3' (Chr3: 100, 815, 853-100, 815, 872; ENSRNOG00000047466) and RV 5'-AGCA 815, 815, 837; ENSRNOG00000047466) , for BDNF exon I FW 5'-ACACTGAGTCT CCAGGACAGCAA-3' (Chr3: 100, 769, 241-100, 769, 266; ENSRNOG00000047466) and RV 5'-TGCAACCGAAGTATGAAAT AACCA-3 (Chr3: 100, 815, 600-100, 815, 626; ENSRN OG00000047466), for BDNF exon IV FW 5'-AGCTAGCATGAAA TCTCCCAGTCT-3' (Chr 3: 100, 786, 926-100, 786, 952; ENSRNOG00000047466) and RV 5'-GGTAATACTCGCACGCCTTCA G-3 (Chr3: 100, 786, 976-100, 787, 000; ENSRNOG00000047466), and Hypoxanthine phosphoribosyl-transferase (HPRT) (Formisano et al., 2015b) as reference gene. For the evaluation of miRNAs levels, total RNA enriched in miRNAs, was extracted with MirVana extraction Kit according to manufacturer's protocol (Applied Biosystems). The first-strand cDNA was synthesized 50 ng of total RNA using the TaqMan miRNA reverse transcription Kit (cod: 4366596, ThermoFisher). Amplification was performed using TaqMan probes in a 7500 Fast real-time PCR system with the following primers: (1) miR206-3p (batch ID 00510 miRNA mature sequence detection, Valsecchi et al., 2015) , and Ribosomal Protein L19 (L19) as reference gene (batch ID Rn00821265_g1). The following cycling conditions were used: 50 C for 2 min, 95 C for 10 min, followed by 40 cycles of 95 C for 1 min, 60 C for 1 min, and 72 C for 30 s. Changes in mRNAs and miRNAs expression between groups were represented as the mean of the relative quantification (RQ) values that was calculated as the difference in threshold cycle (DCt) between the target gene and the reference gene (2 ÀDDCT ¼ RQ).
Western blotting analysis. Neurons were lysed in ice-cold lysis buffer and quantified as previously reported . Loaded proteins were 80 mg for REST, HDAC4, Sp1, Sp4, and JunD, and 100 mg for BDNF, and 50 mg for caspase-3. REST, HDAC4, Sp1, Sp4, and JunD were separated on 8% SDS polyacrylamide gels, whereas for BNDF, caspase-3, and ubiquitin 12% SDS polyacrylamide gels. The membranes were incubated overnight at 4 C in the blocking buffer with polyclonal antibodies against REST (Iannotti et al., 2013) , HDAC4 (Guida et al., 2016) , Sp1 , Sp4 , BDNF (Guida et al., 2017a) , JunD (cod: PA5-38138, ThermoFisher, Milan, Italy), caspase-3 (Formisano et al., 2011) , and monoclonal antibody for Tubulin (T5168, Sigma). In all the experiments the optical density of the bands was normalized to Tubulin.
ChIP assays. ChIP assays were performed with cortical neurons treated with MeHg 1 mM/24 h, alone or after miRNA 206 transfection and by using 5 mg of antibody for JunD or for HDAC4 (Guida et al., 2017a) and all values were normalized for the DNA input.
Determination of cell injury. Neuronal death was evaluated by measuring the release of the enzyme lactate dehydrogenase (LDH) as previously reported in Formisano et al. (2015a) . LDH release was evaluated in the following experimental conditions: (a) (1) vehicle, (2) MeHg 12 h and (3) MeHg 24 h, (b) (1) vehicle, (2) vehicle þ Scr, (3) MeHg, (4) MeHg þ miR206 10 nM, (5) MeHg þ miR206 25 nM, (6) MeHg þ miR206 50 nM, and (7) MeHg þ miR206 75 nM. Cytosolic levels of LDH were measured with the LDH Cytotoxicity Kitfrom Cayman, DBA (Milan, Italy). Shortly, after MeHg treatment at 1 mM for 24 h, the medium was removed and tested for LDH levels, by evaluating the absorbance at 490 nm on a spectrophotometer (BioPhotometer; Eppendorf, Hamburg, Germany). LDH from cells treated with 1% Triton X-100 (Sigma), was used as a positive control, and its value was considered 100%.
Statistical analysis. All comparisons were made using Student's test for the analysis of 2 experimental groups or 1-way ANOVA followed by post hoc Turkey's for the analysis of more than 2 experimental groups, by using Graph-Pad Prism 5 software (La Jolla, Californina). A p < .05 was considered statistically significant.
RESULTS

MeHg Exposure-Induced Neuronal Death by Reducing miR206 Levels in Cortical Cells
A time-course analysis of miR206 levels after MeHg exposure at the concentration of 1 mM, that induces neuronal death as previously reported in Guida et al. (2017a) , revealed that miR206 expression was significantly reduced at 12 and 24 h ( Figure 1A ) . Interestingly, MeHg induced significantly cell death at 24 h but not at 12 h ( Figure 1B) .To verify the role of miR206 in MeHginduced neuronal death, cells were transiently transfected with miR206 at concentrations from 10 to 75 nM. As shown in Figure 1C , miR206 at 50 nM approximately reduced of 50% MeHg-induced cell death. Notably, transfection of miR206 (50 nM/24 h) increased significantly its expression compared with Scr transfected cells ( Figure 1D ). Importantly, miR206 reverted not only MeHg-reduced cell survival ( Figure 1C ), but also MeHginduced cleavage of caspase-3 ( Figure 1E ). These results demonstrate that MeHg-induced miR206 downregulation is not a consequence of cell death, since MeHg-reduced miR206 expression appeared before the occurrence of neuronal death.
miR206 Blocks MeHg-Induced Activation of REST/Sp4/HDAC4/BDNF Axis in Neurons We previously reported that MeHg exposure increased REST, Sp1, Sp4, and HDAC4 with consequent BDNF reduction of in primary cortical nuerons (Guida et al., , 2017a . Therefore, we investigated in MeHg-exposed cortical neurons the effect of miR206 transfection on REST, Sp1, Sp4, HDAC4, and BDNF expression. Our data showed that miR206 significantly reverted the effect of MeHg, reducing REST and Sp4 upregulation and BDNF reduction at transcriptional (Figs. 2A, 2C , and 2E) and protein levels (Figs. 2F, 2H, and 2L). As expected, miR206 counteracted MeHg-induced HDAC4 protein expression ( Figure 2I ), but it did not exert any effect on HDAC4 mRNA ( Figure 2D ). Notably, miR206 was not able to block MeHg-induced Sp1 mRNA and protein upregulation (Figs. 2B and 2G) . Remarkably, these experiments suggested that REST and Sp4 could be new miR206 targets. Notably, miR206 transfection alone: (1) reduced REST and Sp4 and increased BDNF at transcriptional and translational level, (2) reduced HDAC4 protein but not its gene and (3) did not have any effect on SP1 gene and protein expression ( Supplementary Figs. 1A-L) .
MeHg-Induced miR206 Reduction Increased JunD Expression Determining REST and Sp4
Upregulation Surprisingly, computational analysis by Target Scan software (release 7.1; MIT) did not reveal any putative miR206-binding site in rat 3'-UTR of REST (ENST00000309042.7) and Sp4 (ENST00000222584.3). Therefore, we investigated the potential role of the transcription factor JunD, that is involved in the mechanism of neuronal death regulating REST, Sp4, and BDNF expression after MeHg exposure (Herdegen et al., 1997) . In particular, qRT-PCR and western blot analysis showed that miR206 transfection blocked MeHg-induced JunD mRNA and protein upregulation (Figs. 3A and 3B) . Notably, miR206 transfection alone reduced JunD mRNA and protein, respectively (Supplementary Figs. 2A and 2B) .Then, to assess the role of JunD in MeHg-induced REST, Sp4, and BDNF mRNA and protein modulation, JunD was knocked down in cortical neurons by transfection with a specific siRNA (siJunD). Remarkably, siJunD significantly downregulated JunD protein expression by 58%, as compared with siCTL ( Figure 3C Interestingly, we identified by bioinformatics analysis with TargetScan 7.1 on the 878 bp rat 3'-UTR of JunD (ENST00000252818.3), one conserved miR206 target site at position 472-478, named miR206/JunD, that possesses a higher probability in terms of: (1) site-type, (2) context score, (3) context score percentile, (4) weighted context score, (5) conserved branch, and (6) the probability of conserved targeting (P CT ) (Agarwal et al., 2015) ( Figure 4A ). The putative miR206 binding site in the JunD untranslated region (UTR) showed also a high homology among mammals ( Figure 4B ). To confirm that miR206 directly represses JunD expression, a luciferase gene reporter assay was performed in SH-SY5Y cells. We made 2 different pmiR reporter constructs: the first contained the full length 3-UTR of JunD (3 0 -UTRJunD), and the second one contained miR206/JunD site mutated (3 0 -UTRJunDmut). In a dual luciferase reporter assay, cotransfection of JunD 3 0 -UTR with miR206 caused a 47% of reduction of 3'-UTR JunD luciferase activity, compared with Scr ( Figure 4C ). In contrast, cells transfected with JunD 3 0 -UTRmut construct were not sensitive to miR206 treatment ( Figure 4C ).
JunD Binds REST and Sp4 Promoters in MeHg-Treated Neurons
REST gene is composed of 3 alternative promoters a, b and c that are upstream of 3 exons A, B, and C, respectively. Each of these exons can splice with exon D, that contains the translation start site (Ravache et al., 2010) . Interestingly, REST gene structure is conserved between human and rat species and by sequence genome alignment it has been found that they presented 68% homology (Koenigsberger et al., 2000) . Since in rat cortical neurons the transcripts containing the exon B is the most abundant (Koenigsberger et al., 2000) , we investigated the presence of an AP-1 element that binds JunD (Tong et al., 1998) in the REST promoter b sequence (ENSRNOG00000002074). By a bioinformatic analysis with database Jaspar (Bryne et al., 2008) (jaspar.genereg.net) with a search threshold score of 90.0, we found an AP-1 element, named AP-1-REST, that was situated on chromosome 14 from nucleotide 33152173 to nucleotide 33152184 (Figs. 5A and 5B). ChIP and qRT-PCR experiments revealed that miR206 transfection significantly reduced MeHginduced JunD binding on REST promoter b sequence ( Figure 5C ), and blocked the upregulation of REST transcript level containing the exon B mRNA ( Figure 5D ). Interestingly, miR206 transfection alone reduced JunD binding on REST promoter b sequence and REST exon B transcription, respectively.
( Supplementary Figs. 2C and 2D ). Next, we investigated the role of miR206 to modulate JunD binding on Sp4 promoter sequence. Notably, Sp4 mouse gene consists of 6 exons and 5 introns (Song et al., 2001 ) and its promoter shows 55% homology with rat. Next, by using the database Jaspar, in rat Sp4 promoter sequence we found a JunD binding site, named AP-1-Sp4, located on chromosome 6 from nucleotide 146196254 to nucleotide 146196365 (Figs. 6A and 6B) . ChIP analysis in MeHg-treated neurons showed that miR206 overexpression significantly diminished the binding of JunD on rat Sp4 promoter sequence (Fig. 6C) . Intriguingly, miR206 transfection alone reduced JunD binding on Sp4 promoter sequence (Supplementary Figure 2E) . (Pruunsild et al., 2007) . Each promoter is regulated at different times and brain regions during the development or by several stimuli (Tuvikene et al., 2016) . In particular, MeHg reduces BDNF mRNA and protein expression by increasing HDAC4 binding to BDNF promoter IV sequence (Guida et al., 2017a) . BDNF expression can be regulated also at level of the 3'-UTR, that contains 2 polyadenylation sites; in this way each primary transcript exists in 2 forms, 1 with a short and the other with a long 3'-UTR (Vaghi et al., 2014) . Specifically, in rat cortical neurons miR206 reduced BDNF transcript levels through the presence of 2 miR206 target sites on the long 3'-UTR sequence (Miura et al., 2012; Tapocik et al., 2014) . On the other hand, it has been demonstrated that in neurons JunD, through the binding to the promoter I of BDNF sequence, increased its expression (Tuvikene et al., 2016) . Since we found that miR206 overexpression blocked MeHg-induced BDNF mRNA, and protein reduction (Figs. 2E and 2L) and that it does not occur through JunD (Figs. 5F and 5I), we evaluated the binding of HDAC4 on BDNF promoter IV sequence after miR206 overexpression. ChIP experiments with HDAC4 antibody were achieved using specific primers recognizing rat BDNF promoter IV sequence. In MeHg-treated neurons, when chromatin was immunoprecipitated with the HDAC4 antibody, an increase of signal was detected compared with Scr, that was counteracted by miR206 transfection ( Figure 7A ). Importantly, BDNF exon IV mRNA reduction determined by MeHg was reverted by miR206 transfection ( Figure 7B ). Notably, miR206 transfection alone reduced HDAC4 binding on BDNF promoter IV sequence and increased BDNF exon IV transcript, respectively.
( Supplementary Figs. 2F and 2G) . Furthermore, we studied the effect of MeHg to modulate JunD binding on rat BDNF promoter I. Interestingly, we found that JunD is physically bound to rat BDNF promoter I, but its binding is not significantly modified by MeHg treatment alone or in combination with miR206 ( Figure 7C ). As expected, also the expression of BDNF exon I mRNA after MeHg exposure, alone or in combination with miR206, was not significantly changed ( Figure 7D ). Notably, miR206 overexpression alone did not modify JunD binding on BDNF promoter I sequence and BDNF exon I transcription ( Supplementary Figs. 2H and 2I ).
DISCUSSION
REST/HDAC4/Sp1/Sp4/BDNF axis is a pathway, that once activated, by MeHg exposure contributes to neuronal death as shown in in vitro models (Guida et al., 2017a) . Therefore, the identification of molecular determinants causing its activation could be important for treating neurotoxicity produced by this environmental compound. This article showed for the first time that in neurons exposed to MeHg, miR206 levels were reduced compared with physiological condition, and that its overexpression reverted the neurotoxic effect of MeHg blocking REST, HDAC4, and Sp4 upregulation and BDNF downregulation. Intriguingly, we found that miR206 regulated REST and Sp4 at transcriptional level through the activation of the transcription factor JunD (Figure 8 ). Indeed, JunD knocking-down significantly prevented the increase in REST and Sp4 gene caused by MeHg exposure. Specifically, we found that JunD, by binding an AP-1 consensus site on rat REST and Sp4 gene promoter sequences, termed AP-1-REST and AP-1-Sp4 respectively, upregulated their expression. We identified the AP-1-REST sequence in the REST promoter b fragment, that regulated the expression of REST transcript containing the exon b, that is the most present in neurons (Koenigsberger et al., 2000) . Notably, ChIP revealed that MeHg-induced JunD binding to the AP-1-REST site was blocked by miR206 transfection. Regarding REST promoter, Ravache's group identified other 2 AP-1 motives within the human REST gene (Ravache et al., 2010) , that have not been found in rat REST promoter sequence by sequence aligment. Furthermore, our group previously demonstrated that PCB-95 increases REST expression through c-Jun, that is a member of Jun family (Shaulian and Karin, 2001) . In contrast, in this work we found that c-Jun was not modulated by MeHg treatment (data not shown). Therefore, we considered the involvement of the transcriptional factor JunD. In particular, we found that JunD bound Sp4 promoter sequence determining an increase in its expression. It is noteworthy that JunD can act as a transcriptional repressor (Xiao et al., 2007) or activator (Shaulian and Karin, 2002 ). In our model it was a transcriptional activator of REST and Sp4, since its silencing completely blocked MeHg-induced REST and Sp4 upregulation. Furthermore, JunD increase after MeHg exposure is in agreement with previous papers showing that neurodetrimental stimuli, such as kainate exposure (Kasof et al., 1995) or axotomy, increased its gene and protein expression (Herdegen et al., 1997) . Concerning the regulation of BDNF at neuronal level, it has been demonstrated that miRNA206, by binding its consensus site on the 3'-UTR of BDNF gene, reduced BDNF mRNA and protein expression (Tapocik et al., 2014) , while JunD, through its binding to an AP-1 site on BDNF promoter I gene sequence, activated BDNF transcription (Tuvikene et al., 2016) . We found that in MeHg-exposed neurons miR206 overexpression blocked BDNF mRNA and protein reduction, whereas JunD knockdown had no effect on BDNF expression. Furthermore, we found that JunD binding on BDNF promoter I sequence and the expression of its relative transcript were both unmodified by MeHg treatment, alone or in combination with siJunD. On the other hand, we found that miR206 counteracted HDAC4 binding on BDNF promoter IV gene sequence reducing the expression of BDNF transcript IV. These results are in agreement with our previous paper demonstrating that MeHg, through the increase of HDAC4 binding on human BDNF promoter IV sequence, downregulates its expression (Guida et al., 2017a) . Notably, our study demonstrated for the first time that JunD is a new miR206 target gene. Infact, luciferase reporter assays driven by analyzing the 3 0 -UTR fragment of JunD RNA identified 1 functional miR206 binding site in JunD mRNA, and the miR206 transfection downregulates JunD mRNA and protein expression. Another interesting finding of this article that deserves to be discussed is that miR206 is able to modulate the proapoptotic effect of MeHg in neurons since the miR206 overexpression counteracted MeHg-activated caspase3 cleavage, and consequently cell death. These results are in accordance with the reports in which it has been demonstrated that MeHg induces neuronal death by activating an apoptotic mechanism (Fujimura and Usuki, 2015; Guida et al., 2015b; Ndountse and Chan, 2008) . Finally, a relevant aspect arising from the consideration of this article finding is that neuronal death induced by MeHg exposure could mimic the acceleration of disease progression and the reduction of survival occurring in G93A-SOD1 transgenic mice expressing low copies of miR206 (Williams et al., 2009) . Infact in accordance with our findings, in G93A-SOD1 mice HDAC4 expression is upregulated, as it occurs in our model. In summary, this study shows that MeHg in vitro causes neuronal death also by a miR206 reduction, that leads to an increase of the prodeath proteins REST, Sp4, and HDAC4 and to reduction of the prosurvival protein BDNF. Importantly, REST and Sp4 upregulation occurred through the recruitment of the transcription factor JunD, the expression of which is downregulated by miR206 by reducing its mRNA stability. Furthermore, by overexpressing miR206, cortical neurons were rescued from MeHg-induced caspase 3 activation and apoptosis. Thereby, drugs stimulating miR206 expression might represent a promising therapeutic strategy in neuronal diseases correlated to the exposition of high concentrations of MeHg, such as Minamata disease (Eto et al., 2010) , or where a downregulation of miR206 occurs.
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